Relapse Prevention in the Managed Care Environment
$2.00
{{option.name}}:
{{selected_options[option.position]}}
{{value_obj.value}}
By Terence T. Gorski, August 07, 2001 Relapse prevention is a serious concern of managed care providers who are responsible for containing the cost of chemical dependency treatment. When we look at the relapse rates following treatment, it is easy to understand why. Forty seven percent of patients treated in private treatment programs will return to chemical use within the first year following treatment...
Show More
Show Less